Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (29)
Song-gao Zhang & Yi Huang. (2022) Usefulness of AFP, PIVKA-II, and Their Combination in Diagnosing Hepatocellular Carcinoma Based on Upconversion Luminescence Immunochromatography. Laboratory Medicine 53:5, pages 488-494.
Crossref
Crossref
Young-Suk Lim. (2021) Role of Tumor Biomarkers in the Surveillance of Hepatocellular Carcinoma. The Korean Journal of Gastroenterology 78:5, pages 284-288.
Crossref
Crossref
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac & Giovanni Casazza. (2021) Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2021:4.
Crossref
Crossref
Vijay Pandyarajan, Rajalakshmi Govalan & Ju Dong Yang. (2021) Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma. International Journal of Molecular Sciences 22:2, pages 479.
Crossref
Crossref
Yu‐Yan Pang, Jian‐Di Li, Li Gao, Xia Yang, Yi‐Wu Dang, Ze‐Feng Lai, Li‐Min Liu, Jie Yang, Hua‐Yu Wu, Rong‐Quan He, Zhi‐Guang Huang, Dan‐Dan Xiong, Li‐Hua Yang, Lin Shi, Wei‐Jia Mo, Deng Tang, Hui‐Ping Lu & Gang Chen. (2020) The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues. Cancer Medicine 9:21, pages 8004-8019.
Crossref
Crossref
Jia Fan, Yu Chen, Dan Zhang, Juan Yao, Zijun Zhao, Yao Jiang, Yiqin Li & Yongcan Guo. (2020) Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis. Surgical Oncology 34, pages 245-255.
Crossref
Crossref
Jiaxin Zhang, Guang Chen, Peng Zhang, Jiaying Zhang, Xiaoke Li, Da’nan Gan, Xu Cao, Mei Han, Hongbo Du & Yong’an Ye. (2020) The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. PLOS ONE 15:2, pages e0228857.
Crossref
Crossref
Zhaobo Liu, Min Wu, Dongdong Lin & Ning Li. (2020) Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma. Journal of International Medical Research 48:2, pages 030006052090257.
Crossref
Crossref
Jonggi Choi, Gi‐Ae Kim, Seungbong Han, Woochang Lee, Sail Chun & Young‐Suk Lim. (2019) Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early‐Stage Hepatocellular Carcinoma. Hepatology 69:5, pages 1983-1994.
Crossref
Crossref
Hiroshi Yasuda, Masatoshi Nakagawa, Hirofumi Kiyokawa, Eisaku Yoshida, Toru Yoshimura, Naohiko Koshikawa, Fumio Itoh & Motoharu Seiki. (2019) Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review. International Journal of Molecular Sciences 20:1, pages 226.
Crossref
Crossref
Yi Huang, Songgao Zhang, Qingzhu Zheng, Yadong Li, Lili Yu, Qingwei Wu, Jiaying Zheng, Yanan Wu, Funan Qiu, Qi Gao & Jiancheng Zhang. (2019) Development of up-converting phosphor technology-based lateral flow assay for quantitative detection of serum PIVKA-II: Inception of a near-patient PIVKA-II detection tool. Clinica Chimica Acta 488, pages 202-208.
Crossref
Crossref
Hao Xing, Yi-Jie Zheng, Jun Han, Han Zhang, Zhen-Li Li, Wan-Yee Lau, Feng Shen & Tian Yang. (2018) Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis. Hepatobiliary & Pancreatic Diseases International 17:6, pages 487-495.
Crossref
Crossref
Jiu Chen, Guolin Wu & Youdi Li. (2018) Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis. Disease Markers 2018, pages 1-10.
Crossref
Crossref
Xiaoping Wang & Qiaoxia Wang. (2018) Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity. Canadian Journal of Gastroenterology and Hepatology 2018, pages 1-8.
Crossref
Crossref
Huaping Chen, Siyuan Chen, Shan Li, Zhijian Chen, Xuan Zhu, Meiyu Dai, Lingxi Kong, Xiaodan Lv, Zhili Huang & Xue Qin. (2017) Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study. Oncotarget 8:52, pages 90390-90401.
Crossref
Crossref
X. Qin, G. Tang, R. Gao, Z. Guo, Z. Liu, S. Yu, M. Chen, Z. Tao, S. Li, M. Liu, L. Wang, L. Hou, L. Xia, X. Cheng, J. Han & L. Qiu. (2017)
A multicenter study on
PIVKA
reference interval of healthy population and establishment of
PIVKA
cutoff value for hepatocellular carcinoma diagnosis in China
. International Journal of Laboratory Hematology 39:4, pages 392-401.
Crossref
Crossref
Carlo Saitta, Giuseppina Raffa, Angela Alibrandi, Santa Brancatelli, Daniele Lombardo, Gianluca Tripodi, Giovanni Raimondo & Teresa Pollicino. (2017) PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients. Medicine 96:26, pages e7266.
Crossref
Crossref
Guo-Jian Li, Qin-Yan Chen, Tim J. Harrison, Xue-Yan Wang, Li-Ping Hu, Qing-Li Yang, Kai-Wen Li & Zhong-Liao Fang. (2017) Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study. Cancer Biomarkers 18:3, pages 241-248.
Crossref
Crossref
Wataru Okajima, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Takuma Ohashi, Taisuke Imamura, Jun Kiuchi, Keiji Nishibeppu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Ryo Morimura, Hisashi Ikoma, Kazuma Okamoto & Eigo Otsuji. (2017) Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids. World Journal of Gastroenterology 23:31, pages 5650.
Crossref
Crossref
Hao Xing, Cunling Yan, Liming Cheng, Nianyue Wang, Shuyang Dai, Jianyong Yuan, Wenfeng Lu, Zhouchong Wang, Jun Han, Yijie Zheng & Tian Yang. (2016) Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma. Tumor Biology 37:12, pages 15447-15456.
Crossref
Crossref
Wataru Okajima, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Tsutomu Kawaguchi, Shoji Hirajima, Takuma Ohashi, Taisuke Imamura, Jun Kiuchi, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Ryo Moriumura, Hisashi Ikoma, Kazuma Okamoto, Hiroki Taniguchi, Yoshito Itoh & Eigo Otsuji. (2016) Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function. Oncotarget 7:33, pages 53820-53836.
Crossref
Crossref
Chihiro Dohi, Kazuhiro Nouso, Koji Miyahara, Yuki Morimoto, Nozomu Wada, Hideaki Kinugasa, Yasuto Takeuchi, Kenji Kuwaki, Hideki Onishi, Fusao Ikeda, Shinichiro Nakamura, Hidenori Shiraha, Akinobu Takaki & Hiroyuki Okada. (2016) Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma. Hepatology Research 46:9, pages 916-923.
Crossref
Crossref
Ji De, Yi Shen, Jinyu Qin, Li Feng, Yiping Wang & Li Yang. (2016) A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma. Medicine 95:17, pages e3448.
Crossref
Crossref
Kenju Fujita, Hideki Kinukawa, Kenichi Ohno, Yumiko Ito, Haruhisa Saegusa & Toru Yoshimura. (2015) Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II. Clinical Biochemistry 48:18, pages 1330-1336.
Crossref
Crossref
Mi Na Kim, Kwang-Hyub Han & Sang Hoon Ahn. (2015) Prevention of Hepatocellular Carcinoma: Beyond Hepatitis B Vaccination. Seminars in Oncology 42:2, pages 316-328.
Crossref
Crossref
Ming Chen, Tenghao Zheng, Shuangyin Han, Lida Zhang, Yangqiu Bai, Xinhui Fang, Song-Ze Ding & Yuxiu Yang. (2015) A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients. Clinics and Research in Hepatology and Gastroenterology 39:2, pages 215-221.
Crossref
Crossref
Seung In Seo. (2015) Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma. World Journal of Gastroenterology 21:13, pages 3928.
Crossref
Crossref
Changzai Li, Zhiming Zhang, Pan Zhang & Jianyong Liu. (2014) Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review. Hepatology Research 44:10, pages E11-E25.
Crossref
Crossref
Rong Zhu, Jing Yang, Ling Xu, Weiqi Dai, Fan Wang, Miao Shen, Yan Zhang, Huawei Zhang, Kan Chen, Ping Cheng, Chengfen Wang, Yuanyuan Zheng, Jingjing Li, Jie Lu, Yingqun Zhou, Dong Wu & Chuanyong Guo. (2014)
Diagnostic Performance of Des-
γ
-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis
. Gastroenterology Research and Practice 2014, pages 1-9.
Crossref
Crossref